Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic Fibrosis

BACKGROUND: There are controversies about the most effective treatment to eradicate first growth of Pseudomonas aeruginosa (P aeruginosa) from the lower airways of patients with cystic fibrosis (CF). UK guidelines recommend oral treatment, but some advocate intravenous (IV) treatment. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickey, Helen R, Jones, Ashley P, Lenney, Warren, Williamson, Paula R, Smyth, Rosalind L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832639/
https://www.ncbi.nlm.nih.gov/pubmed/20137079
http://dx.doi.org/10.1186/1745-6215-11-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832639/
https://www.ncbi.nlm.nih.gov/pubmed/20137079
http://dx.doi.org/10.1186/1745-6215-11-11

Ejemplares similares